AstraZeneca pilots Israeli heart disease detection AI

AstraZeneca and the Bellvitge University Hospital in Spain are launching the first pilot program of the HearO™ app developed by Israel’s  Cordio Medical (see here previously) which can detect heart disease when the patient speaks on a smartphone.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *